middle.news
INOVIQ Advances EXO-OC Algorithm and CAR-Exosome Despite Sample Setback
9:01am on Monday 13th of July, 2026 AEST
•
Biotechnology
Read Story
INOVIQ Advances EXO-OC Algorithm and CAR-Exosome Despite Sample Setback
9:01am on Monday 13th of July, 2026 AEST
Key Points
EXO-OC™ clinical validation stalled by sample quality issues
Algorithm optimisation boosts sensitivity to over 92%
CAR-exosomes kill up to 90% of ovarian cancer cells in vitro
Cash position strong at A$9.35 million with disciplined spending
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE